BioSpace News Archive

HB Natural Ingredients has received a “Letter of No Objection” for Vitosa® stevia sweeteners from the U.S. Food and Drug Administration (FDA).

Introduction of Orbital Atherectomy Expands Treatment Options for Patients with Peripheral Artery Disease

While Both iStent and iStent inject Showed Significant IOP and Medication Reduction in Combo-Cataract Procedures at 1 Year Postoperative, iStent inject Achieved Greater Absolute IOP Declines with 93% of Subjects Medication-Free vs. 76% of iStent Subjects

Will report its financial results for the third quarter and nine month period ended September 30, 2019 after the market closes on Thursday, November 7, 2019.

Dr. Charles Brenner, the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa, receives a research grant from the Bill & Melinda Gates Foundation to study the effects of NAD-boosting supplements on the production of bioactive factors in milk and the effect of the supplements on brain development in animals.

Insera Therapeutics, Inc. announced that the first two ischemic stroke patients have been treated with its flagship cyclic aspiration system, CLEARTM.

Kramer Laboratories, Inc., a healthcare company that delivers innovative products to help consumers self-treat their everyday problems, announced today that it has changed its corporate name to Arcadia Consumer Healthcare, Inc.

Varian (NYSE: VAR) will showcase the company’s interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 in Miami, Fla.

Integration of Genomic, Transcriptomic, Proteomic and Imaging Analysis aimed at Understanding Cancer Progression and Tumor Microenvironment Involvement